Immunotherapy of chronic inflammatory demyelinating polyneuropathy;Immuntherapie der chronisch inflammatorischen demyelinisierenden polyneuropathie

Fortschritte der Neurologie Psychiatrie

Volumn 72, Issue 12, 2004, Pages 672-678

  Lünemann, Jan D ^a,b   Prass, K ^a   Zschenderlein, R ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AZATHIOPRINE; BETA INTERFERON; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETANERCEPT; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL FEATURE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; IMMUNOTHERAPY; MUSCLE WEAKNESS; PERIPHERAL NERVOUS SYSTEM; PLASMAPHERESIS; PREVALENCE; REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME;

CHRONIC DISEASE; DEMYELINATING DISEASES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; IMMUNOTHERAPY; INTERFERON TYPE I, RECOMBINANT; PLASMAPHERESIS; POLYNEUROPATHIES;

EID: 10844233895     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-830039     Document Type: Review

References (44)

1. Austin JH. Recurrent polyneuropathies and their corticosteroid treatment; with five-year observations of a placebo-controlled case treated with corticotrophin, cortisone, and prednisone. Brain 1958; 81: 57-192
2. Thomas PK, Lascelles RG, Hallpike JF, Hewer RL. Recurrent and chronic relapsing Guillain-Barré polyneuritis. Brain 1969; 92: 589-606
3. Dyck PJ, O'Brien PC, Oviatt KF et al. Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol 1982; 11: 136-141
4. McLeod JG, Pollard JD, Macaskill P, Mohamed A, Spring P, Khurana V. Prevalence of chronic inflammatory demyelinating polyneuropathy in New South Wales, Australia. Ann Neurol 1999; 46: 910-913
5. Lunn MP, Manji H, Choudhary PP, Hughes RA, Thomas PK. Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England. J Neurol Neurosurg Psychiatry 1999; 66: 677-680
6. Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 1991; 41: 617-618
7. Barohn RJ, Kissel JT, Warmolts JR, Mendell JR. Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria. Arch Neurol 1989; 46: 878-884
8. Saperstein DS, Katz JS, Amato AA, Barohn RJ. Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve 2001; 24: 311-324
9. Koller H, Kieseier BC, Jander S, Hartung HP. [Chronic inflammatory demyelinating polyneuropathy]. Nervenarzt 2003; 74: 320-233
10. Sander HW, Latov N. Research criteria for defining patients with CIDP. Neurology 2003; 60: S8-15
11. Katz JS, Saperstein DS, Gronseth G, Amato M, Barohn RJ. Distal acquired demyelinating symmetric neuropathy. Neurology 2000; 54: 615-620
12. Kieseier BC, Dalakas MC, Hartung HP. Immune mechanisms in chronic inflammatory demyelinating neuropathy. Neurology 2002; 59: S7-12
13. Dalakas MC. Advances in chronic inflammatory demyelinating polyneuropathy: disease variants and inflammatory response mediators and modifiers. Curr Opin Neurol 1999; 12: 403-409
14. Dalakas MC, Engel WK. Chronic relapsing (dysimmune) polyneuropathy: pathogenesis and treatment. Ann Neurol 1981; 9 Suppl: 134-145
15. McCombe PA, Pollard JD, McLeod JG. Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases. Brain 1987; 110 (Pt 6): 1617-1630
16. Molenaar DS, Doorn PA van, Vermeulen M. Pulsed high dose dexamethasone treatment in chronic inflammatory demyelinating polyneuropathy: a pilot study. J Neurol Neurosurg Psychiatry 1997; 62: 388-390
17. Dyck PJ, O'Brien P, Swanson C, Low P, Daube J. Combined azathioprine and prednisone in chronic inflammatory-demyelinating polyneuropathy. Neurology 1985; 35: 1173-1176
18. British and Dutch Multiple Sclerosis Azathioprine Trial Group. Double-masked trial of azathioprine in multiple sclerosis. Lancet 1988; 2: 179-183
19. Hughes RA, Swan AV, Doorn PA van. Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev, 2003; CD003280
20. Confavreux C, Saddier P, Grimaud J, Moreau T, Adeleine P, Aimard G. Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study. Neurology 1996; 46: 1607-1612
21. Levy RL, Newkirk R, Ochoa J. Treating chronic relapsing Guillain-Barré-syndrome by plasma exchange. Lancet 1979; 2: 259-260
22. Dyck PJ, Daube J, O'Brien P et al. Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy. N Engl J Med 1986; 314: 461-465
23. Hahn AF, Bolton CF, Pillay N et al. Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study. Brain 1996; 119 (Pt 4): 1055-1066
24. Madden RD, Bensa S, Lunn MP, Hughes RA. Immunoadsorption inferior to plasma exchange in a patient with chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Neurosurg Psychiatry 2002; 72: 644-646
25. Choudhary PP, Hughes RA. Long-term treatment of chronic inflammatory demyelinating polyradiculoneuropathy with plasma exchange or intravenous immunoglobulin. Qjm 1995; 88: 493-502
26. Rizvi MA, Vesely SK, George JN et al. Complications of plasma exchange in 71 consecutive patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic-uremic syndrome. Transfusion 2000; 40: 896-901
27. Hahn AF, Bolton CF, Zochodne D, Feasby TE. Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study. Brain 1996; 119 (Pt 4): 1067-1077
28. Mendell JR, Barohn RJ, Freimer ML et al. Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy. Neurology 2001; 56: 445-449
29. Thompson N, Choudhary P, Hughes RA, Quinlivan RM. A novel trial design to study the effect of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol 1996; 243: 280-285
30. Vermeulen M, Doorn PA van, Brand A, Strengers PF, Jennekens FG, Busch HF. Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled study. J Neurol Neurosurg Psychiatry 1993; 56: 36-39
31. Schaik IN van, Winer JB, De Haan R, Vermeulen M. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev, 2002; CD001797
32. Dyck PJ, Litchy WJ, Kratz KM et al. A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 1994; 36: 838-845
33. Brannagan 3rd TH. Intravenous gammaglobulin (IVIg) for treatment of CIDP and related immune-mediated neuropathies. Neurology 2002; 59: 533-40
34. Hughes R, Bensa S, Willison H et al. Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 2001; 50: 195-201
35. Bouchard C, Lacroix C, Plante V et al. Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy. Neurology 1999; 52: 498-503
36. Good JL, Chehrenama M, Mayer RF, Koski CL. Pulse cyclophosphamide therapy in chronic inflammatory demyelinating polyneuropathy. Neurology 1998; 51: 1735-1738
37. Brannagan 3rd TH, Pradhan A, Heiman-Patterson T et al. High-dose cyclophosphamide without stem-cell rescue for refractory CIDP. Neurology 2002; 58: 1856-1858
38. Hodgkinson SJ, Pollard JD, McLeod JG. Cyclosporin A in the treatment of chronic demyelinating polyradiculoneuropathy. J Neurol Neurosurg Psychiatry 1990; 53: 327-330
39. Kuntzer T, Radziwill AJ, Lettry-Trouillat R et al. Interferon-β1a in chronic inflammatory demyelinating polyneuropathy. Neurology 1999; 53: 1364-1365
40. Hadden RD, Sharrack B, Bensa S, Soudain SE, Hughes RA. Randomized trial of Interferon β-1 a in chronic inflammatory demyelinating polyradiculoneuropathy. Neurology 1999; 53: 57-61
41. Vallat JM, Hahn AF, Leger JM et al. Interferon β-1a as an investigational treatment for CIDP. Neurology 2003; 60: S23-28
42. Gorson KC, Allam G, Simovic D, Ropper AH. Improvement following interferon-α 2A in chronic inflammatory demyelinating polyneuropathy. Neurology 1997; 48: 777-780
43. Chin RL, Sherman WH, Sander HW, Hays AP, Latov N. Etanercept (Enbrel) therapy for chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 2003; 210: 19-21
44. Vermeulen M, Oers MH van. Successful autologous stem cell transplantation in a patient with chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 2002; 72: 127-128